Intuitive Surgical Future Growth
Future criteria checks 2/6
Intuitive Surgical is forecast to grow earnings and revenue by 12.8% and 12% per annum respectively. EPS is expected to grow by 12.5% per annum. Return on equity is forecast to be 14.8% in 3 years.
Key information
12.8%
Earnings growth rate
12.5%
EPS growth rate
Medical Equipment earnings growth | 12.1% |
Revenue growth rate | 12.0% |
Future return on equity | 14.8% |
Analyst coverage | Good |
Last updated | 11 Apr 2025 |
Recent future growth updates
Recent updates
Intuitive Surgical: Premium Valuation Meets Mounting Headwinds (Downgrade)
Apr 11Weekly Picks: ⛏️ Barrick Gold's Prospects, Intuitive Surgical's Moat, and Tullow Oil's Potential Upside
Apr 02
From Battle Field to Robotic Surgery
Mar 30Intuitive Surgical (ISRG) is a pioneer in robotic-assisted surgery, revolutionizing the medical field with its da Vinci surgical system. Founded in 1995, the company has continuously innovated, making
Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth
Mar 18Increased Adoption of Robotic Surgery:Hospitals and surgical centers continue to adopt Intuitive Surgical’s da Vinci systems as clinical evidence shows improved outcomes and reduced recovery times.ExpIntuitive Surgical: Getting Closed To Its Fair Value
Mar 09If EPS Growth Is Important To You, Intuitive Surgical (NASDAQ:ISRG) Presents An Opportunity
Mar 02Intuitive Surgical: The Robot Is Well-Oiled
Jan 28Intuitive Surgical: Second Half 2025 Guidance Is Critical To Maintaining Current Euphoria
Jan 20Intuitive Surgical (NASDAQ:ISRG) Hasn't Managed To Accelerate Its Returns
Jan 17Revenues Tell The Story For Intuitive Surgical, Inc. (NASDAQ:ISRG)
Dec 30Intuitive Surgical: Growing Impressively, But It Appears Overvalued
Dec 27Intuitive Surgical: One Of The Best Business Models In The World, But Not At This Price
Nov 14Intuitive Surgical Q3: Da Vinci 5 Robot Set For 2025, But Overvalued
Oct 18Intuitive Surgical (NASDAQ:ISRG) Is Reinvesting At Lower Rates Of Return
Oct 04Intuitive Surgical Offers Low Risk, High Return Despite Valuation Concerns
Sep 24What You Can Learn From Intuitive Surgical, Inc.'s (NASDAQ:ISRG) P/S
Sep 16Intuitive Surgical: Detached From Fundamentals
Aug 26Da Vinci 5 Launch And Digital Expansion Set To Revolutionize Surgical Efficiency And Drive Growth
Aug 20 Launch of da Vinci 5 systems and expansion in digital services like My Intuitive app show promise for revenue growth and operational efficiency.Intuitive Surgical: A Lofty Price To Pay For Innovation, Wait For A Better Entry Point
Aug 20There May Be Underlying Issues With The Quality Of Intuitive Surgical's (NASDAQ:ISRG) Earnings
Jul 26Intuitive Surgical: Shares Surge, But Now Near Fair Value (Rating Downgrade)
Jul 12Does Intuitive Surgical (NASDAQ:ISRG) Deserve A Spot On Your Watchlist?
Jul 11There Are Reasons To Feel Uneasy About Intuitive Surgical's (NASDAQ:ISRG) Returns On Capital
Jun 25What Is Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Share Price Doing?
Jun 10Intuitive Surgical: Sell Signals Abound
May 17Intuitive Surgical, Inc.'s (NASDAQ:ISRG) CEO Compensation Looks Acceptable To Us And Here's Why
Apr 19Intuitive Surgical: Growth And Margins Will Be Challenged In 2024
Apr 12Intuitive Surgical: Buy A 'Little Slice' Of The Future
Jan 29Intuitive Surgical: Strong Pre-Announced Q4 - Time To Harvest The Gain, Initiate With 'Sell'
Jan 13Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 12,682 | 3,431 | 4,036 | 4,962 | 20 |
12/31/2026 | 11,091 | 2,952 | 3,633 | 4,332 | 30 |
12/31/2025 | 9,598 | 2,490 | 3,038 | 3,740 | 30 |
12/31/2024 | 8,352 | 2,323 | 1,304 | 2,415 | N/A |
9/30/2024 | 7,867 | 2,243 | 586 | 1,821 | N/A |
6/30/2024 | 7,573 | 2,094 | 420 | 1,663 | N/A |
3/31/2024 | 7,319 | 1,988 | 596 | 1,708 | N/A |
12/31/2023 | 7,124 | 1,798 | 750 | 1,814 | N/A |
9/30/2023 | 6,851 | 1,517 | 1,256 | 2,023 | N/A |
6/30/2023 | 6,665 | 1,425 | 1,178 | 1,858 | N/A |
3/31/2023 | 6,431 | 1,312 | 1,006 | 1,639 | N/A |
12/31/2022 | 6,222 | 1,322 | 958 | 1,491 | N/A |
9/30/2022 | 6,118 | 1,378 | 1,091 | 1,621 | N/A |
6/30/2022 | 5,964 | 1,435 | 1,310 | 1,739 | N/A |
3/31/2022 | 5,906 | 1,644 | 1,460 | 1,835 | N/A |
12/31/2021 | 5,710 | 1,705 | 1,750 | 2,089 | N/A |
9/30/2021 | 5,489 | 1,689 | 1,885 | 2,149 | N/A |
6/30/2021 | 5,163 | 1,623 | 1,662 | 1,922 | N/A |
3/31/2021 | 4,551 | 1,173 | 1,315 | 1,610 | N/A |
12/31/2020 | 4,358 | 1,061 | 1,143 | 1,485 | N/A |
9/30/2020 | 4,307 | 1,053 | 988 | 1,410 | N/A |
6/30/2020 | 4,358 | 1,136 | 1,088 | 1,532 | N/A |
3/31/2020 | 4,604 | 1,386 | 1,202 | 1,618 | N/A |
12/31/2019 | 4,479 | 1,379 | 1,173 | 1,598 | N/A |
9/30/2019 | 4,247 | 1,314 | 1,045 | 1,384 | N/A |
6/30/2019 | 4,040 | 1,210 | 1,008 | 1,307 | N/A |
3/31/2019 | 3,850 | 1,147 | 961 | 1,223 | N/A |
12/31/2018 | 3,724 | 1,128 | 982 | 1,170 | N/A |
9/30/2018 | 3,570 | 804 | N/A | 1,164 | N/A |
6/30/2018 | 3,457 | 810 | N/A | 1,198 | N/A |
3/31/2018 | 3,306 | 778 | N/A | 1,183 | N/A |
12/31/2017 | 3,138 | 671 | N/A | 1,144 | N/A |
9/30/2017 | 3,003 | 906 | N/A | 1,142 | N/A |
6/30/2017 | 2,878 | 819 | N/A | 1,057 | N/A |
3/31/2017 | 2,790 | 780 | N/A | 1,102 | N/A |
12/31/2016 | 2,707 | 738 | N/A | 1,087 | N/A |
9/30/2016 | 2,619 | 722 | N/A | 1,041 | N/A |
6/30/2016 | 2,522 | 678 | N/A | 952 | N/A |
3/31/2016 | 2,434 | 628 | N/A | 875 | N/A |
12/31/2015 | 2,367 | 589 | N/A | 806 | N/A |
9/30/2015 | 2,285 | 546 | N/A | 683 | N/A |
6/30/2015 | 2,250 | 502 | N/A | 654 | N/A |
3/31/2015 | 2,179 | 472 | N/A | 623 | N/A |
12/31/2014 | 2,132 | 419 | N/A | 665 | N/A |
9/30/2014 | 2,082 | 438 | N/A | 700 | N/A |
6/30/2014 | 2,031 | 471 | N/A | 753 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ISRG's forecast earnings growth (12.8% per year) is above the savings rate (2.8%).
Earnings vs Market: ISRG's earnings (12.8% per year) are forecast to grow slower than the US market (13.5% per year).
High Growth Earnings: ISRG's earnings are forecast to grow, but not significantly.
Revenue vs Market: ISRG's revenue (12% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: ISRG's revenue (12% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ISRG's Return on Equity is forecast to be low in 3 years time (14.8%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/04/14 04:03 |
End of Day Share Price | 2025/04/11 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Intuitive Surgical, Inc. is covered by 60 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
David Toung | Argus Research Company |
null null | Argus Research Company |
Richard Purkiss | Atlantic Equities LLP |